AbbVie Inc. - COM (ABBV)

Historical Holders from Q1 2014 to Q1 2025

Symbol
ABBV on NYSE
CUSIP
00287Y109
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.27B
Holdings value
$226B
% of all portfolios
0.221%
Grand Portfolio weight change
+0.01%
Number of holders
3641
Number of buys
1582
Number of sells
-1505
Average Value change %
-0.04%
Average buys %
+0.017%
Average sells %
-0.058%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AbbVie Inc. - COM (ABBV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 28.7M $6.01B -$313M $209.52 750
2024 Q4 1.27B $226B +$5.47B $177.70 3,641
2024 Q3 1.24B $244B -$4.55B $197.48 3,455
2024 Q2 1.26B $216B +$5.77B $171.52 3,308
2024 Q1 1.23B $223B -$1.13B $182.10 3,350
2023 Q4 1.24B $192B +$4.76B $154.97 3,230
2023 Q3 1.2B $180B +$1.11B $149.06 3,043
2023 Q2 1.19B $161B -$4.63B $134.73 3,008
2023 Q1 1.2B $192B -$60.5M $159.37 3,070
2022 Q4 1.21B $195B +$2.81B $161.61 3,098
2022 Q3 1.19B $160B +$794M $134.21 2,910
2022 Q2 1.08B $165B +$2.65B $153.16 2,945
2022 Q1 1.07B $173B +$2.31B $162.11 2,992
2021 Q4 1.06B $143B +$940M $135.40 2,927
2021 Q3 1.17B $127B -$407M $107.87 2,617
2021 Q2 1.18B $133B -$635M $112.64 2,637
2021 Q1 1.18B $128B -$1.09B $108.22 2,577
2020 Q4 1.2B $128B -$1.06B $107.15 2,558
2020 Q3 1.2B $105B -$1.24B $87.59 2,337
2020 Q2 1.19B $117B +$14.5B $98.18 2,381
2020 Q1 1.07B $81.9B +$955M $76.19 2,194
2019 Q4 1.07B $94.4B +$1.22B $88.54 2,216
2019 Q3 1.02B $77.1B +$1.72B $75.72 1,981
2019 Q2 1.01B $73.4B +$1.42B $72.72 1,997
2019 Q1 1B $80.9B -$1.92B $80.59 2,006
2018 Q4 1.03B $95.2B -$2.25B $92.19 2,039
2018 Q3 1.06B $100B -$305M $94.58 1,938
2018 Q2 1.06B $98.1B -$3.39B $92.65 1,970
2018 Q1 1.1B $104B -$1.23B $94.65 1,995
2017 Q4 1.12B $109B +$368M $96.71 1,975
2017 Q3 1.12B $99.3B +$1.31B $88.86 1,783
2017 Q2 1.1B $79.9B +$1.02B $72.51 1,752
2017 Q1 1.1B $71.4B +$5.87B $65.16 1,716
2016 Q4 1.09B $68.3B -$1.53B $62.62 1,678
2016 Q3 1.11B $70.1B -$876M $63.07 1,633
2016 Q2 1.13B $69.7B +$1.41B $61.91 1,619
2016 Q1 1.1B $63B -$315M $57.12 1,619
2015 Q4 1.11B $66B -$1.78B $59.24 1,624
2015 Q3 1.14B $61.8B -$3.03B $54.41 1,583
2015 Q2 1.17B $78.7B +$5.88B $67.19 1,638
2015 Q1 1.11B $65B -$606M $58.54 1,584
2014 Q4 1.12B $73.1B -$8.41B $65.44 1,589
2014 Q3 1.25B $72.3B +$8.37B $57.76 1,488
2014 Q2 1.11B $62.6B +$2.62B $56.44 1,444
2014 Q1 1.07B $54.8B +$12.1M $51.40 1,408